1. Home
  2. PGEN vs ICHR Comparison

PGEN vs ICHR Comparison

Compare PGEN & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • ICHR
  • Stock Information
  • Founded
  • PGEN 1998
  • ICHR 1999
  • Country
  • PGEN United States
  • ICHR United States
  • Employees
  • PGEN N/A
  • ICHR N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • ICHR Semiconductors
  • Sector
  • PGEN Health Care
  • ICHR Technology
  • Exchange
  • PGEN Nasdaq
  • ICHR Nasdaq
  • Market Cap
  • PGEN 493.0M
  • ICHR 581.2M
  • IPO Year
  • PGEN N/A
  • ICHR 2016
  • Fundamental
  • Price
  • PGEN $3.82
  • ICHR $16.48
  • Analyst Decision
  • PGEN Buy
  • ICHR Strong Buy
  • Analyst Count
  • PGEN 5
  • ICHR 6
  • Target Price
  • PGEN $7.50
  • ICHR $29.80
  • AVG Volume (30 Days)
  • PGEN 9.2M
  • ICHR 781.6K
  • Earning Date
  • PGEN 11-13-2025
  • ICHR 11-03-2025
  • Dividend Yield
  • PGEN N/A
  • ICHR N/A
  • EPS Growth
  • PGEN N/A
  • ICHR N/A
  • EPS
  • PGEN N/A
  • ICHR N/A
  • Revenue
  • PGEN $4,340,000.00
  • ICHR $929,180,000.00
  • Revenue This Year
  • PGEN $253.63
  • ICHR $14.64
  • Revenue Next Year
  • PGEN $699.64
  • ICHR $5.82
  • P/E Ratio
  • PGEN N/A
  • ICHR N/A
  • Revenue Growth
  • PGEN N/A
  • ICHR 15.45
  • 52 Week Low
  • PGEN $0.65
  • ICHR $13.12
  • 52 Week High
  • PGEN $5.23
  • ICHR $36.48
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 54.30
  • ICHR 42.87
  • Support Level
  • PGEN $3.47
  • ICHR $16.60
  • Resistance Level
  • PGEN $4.14
  • ICHR $17.70
  • Average True Range (ATR)
  • PGEN 0.35
  • ICHR 0.78
  • MACD
  • PGEN -0.16
  • ICHR 0.10
  • Stochastic Oscillator
  • PGEN 19.89
  • ICHR 39.73

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.

Share on Social Networks: